Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: the ALL90 study of the Japan Adult Leukemia Study Group.

@article{Ueda1998ResponseorientedII,
  title={Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: the ALL90 study of the Japan Adult Leukemia Study Group.},
  author={Toshiyuki Ueda and Shuichi Miyawaki and Norio Asou and Yasunobu Kuraishi and Akira Hiraoka and Kikuko Kuriyama and Shinya Minami and Toshio Ohshima and Teruo Ino and Jun-ichi Tamura and Akihisa Kanamaru and Kiyoshi Nishikawa and Mitsune Tanimoto and Hakumei Oh and Kazuya Saito and Koichiro Nagata and Tomoki Naoe and O. Yamada and Yoshimasa Urasaki and Tohru Sakura and Ryuzo Ohno},
  journal={International journal of hematology},
  year={1998},
  volume={68 3},
  pages={279-89}
}
Adult patients with acute lymphoblastic leukemia (ALL) were treated according to the ALL90 study, the second prospective study for ALL of the Japan Adult Leukemia Study Group (JALSG). Its characteristics included response-oriented individualized induction therapy with six drugs (doxorubicin, mitoxantrone, vincristine, prednisolone, [corrected] cyclophosphamide and L-asparaginase), and a prospective comparison between allogeneic bone marrow transplantation (allo-BMT) and chemotherapy alone in… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

Similar Papers

Loading similar papers…